Taiho Oncology (United States)

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

Robert J. Mayer, Eric Van Cutsem, Alfredo Falcone et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

NCCN Guidelines Insights: Colon Cancer, Version 2.2018

Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary et al. · Journal of the National Comprehensive Cancer Network · 2018 · 999 citations · Full text

Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in Rats

Yasundo Yamasaki, Naosuke Matsuura, Hidetaka Shozuhara et al. · Stroke · 1995 · 571 citations

Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial

Kohei Shitara, Toshihiko Doi, Mikhail Dvorkin et al. · The Lancet Oncology · 2018 · 495 citations

Gastrointestinal Oncology, Trifluridine/tipiracil Versus Placebo, Medicine +9

Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma

Lipika Goyal, Funda Meric‐Bernstam, Antoine Hollebecque et al. · New England Journal of Medicine · 2023 · 465 citations · Full text